Generic Portal

— Research Explorer

OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1016/j.xcrm.2023.100939
Final published version

Tetje C. van der Sluis
Guillaume Beyrend
Esmé T. I. van der Gracht
Tamim Abdelaal
Simon P. Jochems
Robert A. Belderbos
Thomas H. Wesselink
Suzanne van Duikeren
Floortje J. van Haften
Anke Redeker
Laura F. Ouboter
Elham Beyranvand Nejad
Marcel Camps
Kees L. M. C. Franken
Margot M. Linssen
Peter Hohenstein
Noel F. C. C. de Miranda
Hailiang Mei
John B. A. G. Haanen
Joachim G. Aerts
Ferry Ossendorp
Ramon Arens

Original language	English
Article number	100939
Journal	Cell Reports Medicine
Volume	4
Issue number	3
Early online date	2023
DOIs	https://doi.org/10.1016/j.xcrm.2023.100939
Publication status	Published - 21 Mar 2023

Research areas

immune checkpoint therapy, immunotherapy, mass cytometry, predictive biomarkers, single-cell RNA sequencing, systemic immune activation, T cells

ID: 34550488